transdermal delivery system

Also found in: Dictionary, Thesaurus, Medical.

transdermal delivery system:

see skin patchskin patch,
 transdermal patch,
or transdermal delivery system,
adhesive patch used to deliver a controlled dose of a drug through the skin over a period of time.
..... Click the link for more information.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Transdermal delivery systems (TDS) for the first time in 1970s were entered into the US drug market.
The nitroglycerin transdermal delivery system is indicated for the prevention of angina pectoris due to coronary artery disease.
Pharmaceutical company Actavis Inc (NYSE:ACT) revealed on Monday that the US Food and Drug Administration (FDA) has accepted its filing for its New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) to prevent pregnancy in women.
Earlier this year, the first transdermal delivery system of a stimulant was approved by the Food and Drug Administration.
Its transdermal delivery system attacks pain and irritation at the source for optimal results, says the spokeswoman.
Noven's fentanyl patch is a transdermal delivery system for the management of chronic pain.
M2 EQUITYBITES-June 17, 2016-Agile Therapeutics awarded US patent for progestin patch designs for proprietary transdermal delivery system
Also, the acquisition will provide the buyer with access to NuPathe's proprietary technology including its transdermal delivery system for patients.
13 January 2010 - US-based clinical-stage pharmaceutical company Altea Therapeutics Corporation announced today that it has entered into a partnership with US drug discovery and development company KAI Pharmaceuticals Inc for the preclinical and clinical development of certain KAI proprietary peptides utilizing Altea's proprietary PassPort Transdermal Delivery System.
Most companies have resorted to rereleasing older agents in either longer lasting formulations or, in the case of selegiline, a new, transdermal delivery system.
Reformulation of the classic monoamine oxidase (MAO) inhibitor selegiine into a transdermal delivery system could spar increased use of MAO inhibitors in the treatment of major depression.
Circularity specializes in groundbreaking noninvasive technologies for affordable and portable transdermal delivery systems, and is pursuing regulatory approvals worldwide for device usage as a treatment of disease states related to cardiovascular and microcirculatory blood flow, immunological and autonomic nervous system disorders.